Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome

IgE antibodies against the mammalian oligosaccharide allergen galactose-α-1,3-galactose (αGal) can result in a severe allergic disease known as alpha-gal syndrome (AGS). This syndrome, acquired by tick bites that cause αGal sensitization, leads to allergic reactions after ingestion of non-primate ma...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michael N. Saunders, Claudia M. Rival, Mahua Mandal, Kayla Cramton, Laila M. Rad, Katarzyna W. Janczak, Laura A. Williams, Amogh R. Angadi, Jessica J. O’Konek, Lonnie D. Shea, Loren D. Erickson
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-08-01
Col·lecció:	Frontiers in Allergy
Matèries:	nanoparticle tolerance IgE sensitization carbohydrates galactose-α-1 3-galactose
Accés en línia:	https://www.frontiersin.org/articles/10.3389/falgy.2024.1437523/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!